C/EBP	B-protein
beta	I-protein
regulation	O
of	O
the	O
tumor	B-DNA
necrosis	I-DNA
factor	I-DNA
alpha	I-DNA
gene	I-DNA
.	O

Activated	B-cell_type
macrophages	I-cell_type
contribute	O
to	O
chronic	O
inflammation	O
by	O
the	O
secretion	O
of	O
cytokines	B-protein
and	O
proteinases	B-protein
.	O

Tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF	B-protein
alpha	I-protein
)	O
is	O
particularly	O
important	O
in	O
this	O
process	O
because	O
of	O
its	O
ability	O
to	O
regulate	O
other	O
inflammatory	O
mediators	O
in	O
an	O
autocrine	O
and	O
paracrine	O
fashion	O
.	O

The	O
mechanism	O
(	O
s	O
)	O
responsible	O
for	O
the	O
cell	O
type-specific	O
regulation	O
of	O
TNF	B-protein
alpha	I-protein
is	O
not	O
known	O
.	O

We	O
present	O
data	O
to	O
show	O
that	O
the	O
expression	O
of	O
TNF	B-protein
alpha	I-protein
is	O
regulated	O
by	O
the	O
transcription	B-protein
factor	I-protein
C/EBP	B-protein
beta	I-protein
(	O
NF-IL6	B-protein
)	O
.	O

C/EBP	B-protein
beta	I-protein
activated	O
the	O
TNF	B-DNA
alpha	I-DNA
gene	I-DNA
promoter	I-DNA
in	O
cotransfection	O
assays	O
and	O
bound	O
to	O
it	O
at	O
a	O
site	O
which	O
failed	O
to	O
bind	O
the	O
closely	O
related	O
protein	O
C/EBP	B-protein
alpha	I-protein
.	O

Finally	O
,	O
a	O
dominant-negative	O
version	O
of	O
C/EBP	B-protein
beta	I-protein
blocked	O
TNF	B-DNA
alpha	I-DNA
promoter	I-DNA
activation	O
in	O
myeloid	B-cell_type
cells	I-cell_type
.	O

Our	O
results	O
implicate	O
C/EBP	B-protein
beta	I-protein
as	O
an	O
important	O
regulator	O
of	O
TNF	B-protein
alpha	I-protein
by	O
myelomonocytic	B-cell_type
cells	I-cell_type
.	O

C/EBPB	NULL
Regulation	NULL
of	NULL
the	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Gene	NULL
Richard	NULL
M.	NULL
Pope	NULL
,	NULL
Achim	NULL
Leutz	NULL
,	NULL
*	NULL
and	NULL
Scott	NULL
A.	NULL
Ness	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Arthritis	NULL
and	NULL
Musculoskeletal	NULL
Diseases	NULL
,	NULL
Northwestern	NULL
University	NULL
,	NULL
and	NULL
the	NULL
Veterans	NULL
Administration	NULL
Lakeside	NULL
Medical	NULL
Center	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
60611	NULL
;	NULL
*Zentrum	NULL
fiir	NULL
Molekulare	NULL
Biologie	NULL
,	NULL
Universitit	NULL
Heidelberg	NULL
,	NULL
D-6900	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Molecular	NULL
Biology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Northwestern	NULL
University	NULL
,	NULL
Evanston	NULL
,	NULL
Illinois	NULL
60208	NULL
Abstract	NULL
Activated	NULL
macrophages	NULL
contribute	NULL
to	NULL
chronic	NULL
inflammation	NULL
by	NULL
the	NULL
secretion	NULL
of	NULL
cytokines	NULL
and	NULL
proteinases	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNFa	NULL
)	NULL
is	NULL
particularly	NULL
important	NULL
in	NULL
this	NULL
process	NULL
because	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
regulate	NULL
other	NULL
inflammatory	NULL
mediators	NULL
in	NULL
an	NULL
autocrine	NULL
and	NULL
paracrine	NULL
fashion	NULL
.	NULL

The	NULL
mecha-nism	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
the	NULL
cell	NULL
type-specific	NULL
regulation	NULL
of	NULL
TNFa	NULL
is	NULL
not	NULL
known	NULL
.	NULL

We	NULL
present	NULL
data	NULL
to	NULL
show	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
TNFa	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
C/EBPRG	NULL
(	NULL
NF-IL6	NULL
)	NULL
.	NULL

activated	NULL
the	NULL
TNFa	NULL
gene	NULL
promoter	NULL
in	NULL
cotransfection	NULL
assays	NULL
and	NULL
bound	NULL
to	NULL
it	NULL
at	NULL
a	NULL
site	NULL
which	NULL
failed	NULL
to	NULL
bind	NULL
the	NULL
closely	NULL
related	NULL
protein	NULL
C/EBPa	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
dominant-negative	NULL
version	NULL
of	NULL
C/EBPB	NULL
blocked	NULL
TNFa	NULL
promoter	NULL
activation	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
implicate	NULL
as	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
TNFa	NULL
by	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1994	NULL
.	NULL

94:1449-1455	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
transcription	NULL
factor	NULL
«	NULL
cytokine	NULL
«	NULL
promoter	NULL
«	NULL
inflammation	NULL
Introduction	NULL
Activated	NULL
macrophages	NULL
produce	NULL
an	NULL
array	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
including	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNFa	NULL
)	NULL
,	NULL
interleukins-1	NULL
,	NULL
-6	NULL
,	NULL
and	NULL
-8	NULL
,	NULL
macrophage	NULL
chemotactic	NULL
protein-1	NULL
,	NULL
and	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
la	NULL
(	NULL
MIP-la	NULL
)	NULL
'	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
cytokines	NULL
are	NULL
capable	NULL
of	NULL
both	NULL
attraction	NULL
and	NULL
activation	NULL
of	NULL
additional	NULL
inflammatory	NULL
cells	NULL
and	NULL
induction	NULL
of	NULL
angiogenesis	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
chronic	NULL
inflammation	NULL
,	NULL
such	NULL
as	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
macrophages	NULL
contribute	NULL
directly	NULL
to	NULL
joint	NULL
destruction	NULL
by	NULL
producing	NULL
proteases	NULL
,	NULL
such	NULL
as	NULL
collagenase	NULL
(	NULL
matrix	NULL
metalloproteinase	NULL
1	NULL
)	NULL
and	NULL
stromelysin	NULL
(	NULL
matrix	NULL
metalloproteinase	NULL
3	NULL
)	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

TNFa	NULL
may	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
inflammatory	NULL
process	NULL
,	NULL
since	NULL
it	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
cytokines	NULL
and	NULL
matrix	NULL
metallopro-teinases	NULL
in	NULL
an	NULL
autocrine	NULL
and	NULL
paracrine	NULL
fashion	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Achim	NULL
Leutz	NULL
's	NULL
present	NULL
address	NULL
is	NULL
Max	NULL
Delbriick	NULL
Center	NULL
for	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Robert-Résslay	NULL
Str	NULL
.	NULL

10	NULL
,	NULL
13122	NULL
Berlin	NULL
,	NULL
Germany	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Richard	NULL
M.	NULL
Pope	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Northwestern	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Arthritis	NULL
and	NULL
Connective	NULL
Tissue	NULL
Diseases	NULL
,	NULL
Ward	NULL
3-315	NULL
,	NULL
303	NULL
E.	NULL
Chicago	NULL
Avenue	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60611	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
18	NULL
February	NULL
1994	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
2	NULL
June	NULL
1994	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
c	NULL
,	NULL
chicken	NULL
;	NULL
C/EBP	NULL
,	NULL
CCAAT/en-hancer	NULL
binding	NULL
protein	NULL
;	NULL
cMGF	NULL
,	NULL
chicken	NULL
monocyte	NULL
growth	NULL
factor	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
DN	NULL
,	NULL
dominant-negative	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
h	NULL
,	NULL
human	NULL
;	NULL
MIP-1a	NULL
@	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
la	NULL
;	NULL
r	NULL
,	NULL
rat	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
Volume	NULL
94	NULL
,	NULL
October	NULL
1994	NULL
,	NULL
1449-1455	NULL
A	NULL
variety	NULL
of	NULL
stimuli	NULL
can	NULL
induce	NULL
cells	NULL
to	NULL
produce	NULL
TNFa	NULL
,	NULL
including	NULL
infection	NULL
by	NULL
viruses	NULL
or	NULL
other	NULL
agents	NULL
,	NULL
interaction	NULL
with	NULL
adhesion	NULL
molecules	NULL
,	NULL
or	NULL
treatment	NULL
with	NULL
phorbol	NULL
esters	NULL
,	NULL
endotox-ins	NULL
,	NULL
or	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
or	NULL
even	NULL
TNFa	NULL
itself	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
upstream	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
TNFa	NULL
gene	NULL
has	NULL
revealed	NULL
both	NULL
cell	NULL
type-	NULL
and	NULL
stimulus-specific	NULL
regulatory	NULL
elements	NULL
,	NULL
including	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
(	NULL
15-22	NULL
)	NULL
.	NULL

Although	NULL
many	NULL
cell	NULL
types	NULL
including	NULL
lymphocytes	NULL
,	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
others	NULL
are	NULL
capable	NULL
of	NULL
TNFa	NULL
synthesis	NULL
,	NULL
activated	NULL
mono-cytes/macrophages	NULL
are	NULL
the	NULL
principal	NULL
source	NULL
of	NULL
TNFa	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
how	NULL
the	NULL
TNFa	NULL
gene	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
fashion	NULL
.	NULL

C/EBPS	NULL
(	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
3	NULL
,	NULL
also	NULL
called	NULL
NF-IL6	NULL
,	NULL
NF-M	NULL
,	NULL
LAP	NULL
,	NULL
IL6-DBP	NULL
,	NULL
AGP/EBP	NULL
,	NULL
and	NULL
CRP2	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
termed	NULL
bZip	NULL
proteins	NULL
which	NULL
have	NULL
a	NULL
basic	NULL
DNA-binding	NULL
domain	NULL
linked	NULL
to	NULL
a	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
motif	NULL
.	NULL

It	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
founding	NULL
member	NULL
of	NULL
this	NULL
family	NULL
,	NULL
C/EBPa	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
intimately	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
adipocyte	NULL
differentiation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Earlier	NULL
studies	NULL
identified	NULL
monocytes	NULL
and	NULL
macrophages	NULL
as	NULL
the	NULL
principal	NULL
source	NULL
of	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Cell	NULL
type-specific	NULL
gene	NULL
regulation	NULL
by	NULL
C/EBPS	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
depend	NULL
on	NULL
interactions	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF-kB	NULL
,	NULL
c-jun	NULL
,	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
oncoprotein	NULL
v-Myb	NULL
(	NULL
26-29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
for	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cytokine	NULL
genes	NULL
which	NULL
are	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
including	NULL
the	NULL
genes	NULL
for	NULL
interleukins-1	NULL
,	NULL
-6	NULL
,	NULL
and	NULL
-8	NULL
,	NULL
MIP-la	NULL
,	NULL
and	NULL
chicken	NULL
monocyte	NULL
growth	NULL
factor	NULL
(	NULL
cMGF	NULL
)	NULL
(	NULL
24	NULL
,	NULL
30-35	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
factor	NULL
may	NULL
be	NULL
an	NULL
important	NULL
activator	NULL
of	NULL
inflammation	NULL
and	NULL
of	NULL
growth	NULL
regulatory	NULL
genes	NULL
.	NULL

Finally	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
Myb	NULL
and	NULL
C/	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
myeloid-specific	NULL
genes	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
,	NULL
implicating	NULL
C/EBPS	NULL
as	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
relationship	NULL
between	NULL
C/EBP	NULL
}	NULL
activity	NULL
and	NULL
TNFa	NULL
expression	NULL
.	NULL

We	NULL
identified	NULL
a	NULL
specific	NULL
binding	NULL
site	NULL
for	NULL
in	NULL
the	NULL
TNFa	NULL
gene	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
C/EBP	NULL
directly	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
cytokine	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
in	NULL
cotransfection	NULL
assays	NULL
and	NULL
found	NULL
that	NULL
C/EBP/3	NULL
,	NULL
more	NULL
strongly	NULL
than	NULL
C/EBPa	NULL
,	NULL
activated	NULL
a	NULL
TNFa	NULL
promoter-reporter	NULL
construct	NULL
.	NULL

Furthermore	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
C/EBPA	NULL
was	NULL
able	NULL
to	NULL
block	NULL
activation	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
by	NULL
endogenous	NULL
transcription	NULL
factors	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
C/EBP/	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
TNFa	NULL
gene	NULL
and	NULL
that	NULL
it	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
cell	NULL
type-specific	NULL
regulation	NULL
of	NULL
the	NULL
TNFa	NULL
gene	NULL
in	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Methods	NULL
Cell	NULL
lines	NULL
.	NULL

The	NULL
human	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
U937	NULL
and	NULL
THP-1	NULL
and	NULL
the	NULL
Jurkat	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
C/EBP	NULL
{	NULL
3	NULL
Regulates	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Expression	NULL
1449	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
.	NULL

HD-11	NULL
,	NULL
an	NULL
MC29	NULL
virus	NULL
(	NULL
v-myc	NULL
onco-gene	NULL
)	NULL
transformed	NULL
chicken	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
8	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
3	NULL
%	NULL
chicken	NULL
serum	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
as	NULL
above	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
human	NULL
expression	NULL
vector	NULL
which	NULL
expresses	NULL
the	NULL
NF-IL6	NULL
cDNA	NULL
under	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
(	NULL
from	NULL
S.	NULL
Akira	NULL
,	NULL
Osaka	NULL
University	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
has	NULL
been	NULL
described	NULL
(	NULL
24	NULL
)	NULL
,	NULL
as	NULL
have	NULL
similar	NULL
plasmids	NULL
that	NULL
express	NULL
full-length	NULL
chicken	NULL
C/EBPS	NULL
(	NULL
cC/EBP	NULL
#	NULL
,	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
NF-M	NULL
)	NULL
and	NULL
the	NULL
5D229	NULL
dominant-negative	NULL
deletion	NULL
mutant	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
plasmid	NULL
expresses	NULL
a	NULL
protein	NULL
having	NULL
an	NULL
NH	NULL
;	NULL
-terminal	NULL
deletion	NULL
so	NULL
that	NULL
only	NULL
the	NULL
last	NULL
229	NULL
amino	NULL
acids	NULL
remain	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
92	NULL
%	NULL
identical	NULL
and	NULL
99	NULL
%	NULL
homologous	NULL
to	NULL
its	NULL
human	NULL
counterpart	NULL
,	NULL
and	NULL
the	NULL
COOH-terminal	NULL
212	NULL
amino	NULL
acids	NULL
,	NULL
representing	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
leucine	NULL
zipper	NULL
domains	NULL
,	NULL
are	NULL
99	NULL
%	NULL
identical	NULL
.	NULL

The	NULL
TNFa	NULL
promoter-luciferase	NULL
reporter	NULL
plasmids	NULL
have	NULL
been	NULL
described	NULL
(	NULL
15	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
pCDM8	NULL
expression	NULL
vector	NULL
plasmid	NULL
was	NULL
purchased	NULL
from	NULL
Invitrogen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
follows	NULL
.	NULL

On	NULL
the	NULL
day	NULL
before	NULL
transfec-tion	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
split	NULL
to	NULL
~	NULL
0.7	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

For	NULL
each	NULL
sample	NULL
,	NULL
~	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
2	NULL
ml	NULL
STBS	NULL
(	NULL
25	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
;	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
MgCl	NULL
)	NULL
;	NULL
)	NULL
containing	NULL
750	NULL
pg/ml	NULL
DEAE-dextran	NULL
and	NULL
a	NULL
total	NULL
of	NULL
15	NULL
ug	NULL
of	NULL
CsCl-purified	NULL
plasmid	NULL
DNA	NULL
(	NULL
specific	NULL
plus	NULL
carrier	NULL
)	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
with	NULL
gentle	NULL
inversion	NULL
every	NULL
5	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
3-5	NULL
h	NULL
before	NULL
treatment	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
18-24	NULL
h	NULL
later	NULL
.	NULL

The	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
,	NULL
using	NULL
an	NULL
electroporation	NULL
apparatus	NULL
from	NULL
Invitrogen	NULL
.	NULL

DEAE-dextran-mediated	NULL
transfection	NULL
of	NULL
HD-11	NULL
cells	NULL
and	NULL
luciferase	NULL
assays	NULL
have	NULL
been	NULL
described	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

All	NULL
transfection	NULL
results	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
,	NULL
as	NULL
determined	NULL
using	NULL
an	NULL
assay	NULL
reagent	NULL
from	NULL
Bio-Rad	NULL
Laboratories	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
times	NULL
,	NULL
and	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
independent	NULL
preparations	NULL
of	NULL
DNA	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
U937	NULL
,	NULL
THP-1	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

All	NULL
buffers	NULL
were	NULL
supplemented	NULL
with	NULL
PMSF	NULL
(	NULL
20	NULL
ug/pl	NULL
)	NULL
,	NULL
aprotinin	NULL
,	NULL
pep-statin	NULL
A	NULL
,	NULL
and	NULL
leupeptin	NULL
(	NULL
each	NULL
5	NULL
pg/ml	NULL
)	NULL
.	NULL

For	NULL
expression	NULL
in	NULL
insect	NULL
cells	NULL
,	NULL
the	NULL
cC/EBP3	NULL
CDNA	NULL
was	NULL
transferred	NULL
to	NULL
the	NULL
transfer	NULL
vector	NULL
pVL1392	NULL
and	NULL
transfected	NULL
into	NULL
Sf9	NULL
cells	NULL
along	NULL
with	NULL
linearized	NULL
Baculovirus	NULL
DNA	NULL
using	NULL
a	NULL
kit	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
virus	NULL
was	NULL
used	NULL
to	NULL
infect	NULL
new	NULL
Sf9	NULL
or	NULL
High-5	NULL
cells	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
2	NULL
d	NULL
later	NULL
as	NULL
follows	NULL
.	NULL

All	NULL
buffers	NULL
were	NULL
chilled	NULL
and	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
Tris-X	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-Cl	NULL
,	NULL
pH	NULL
7.3	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
CaCl	NULL
;	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
x	NULL
10'/ml	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
adding	NULL
NP-40	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.5	NULL
%	NULL
,	NULL
then	NULL
the	NULL
nuclei	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
,	NULL
resuspended	NULL
at	NULL
fourfold	NULL
higher	NULL
concentration	NULL
of	NULL
Tris-	NULL
X	NULL
buffer	NULL
plus	NULL
0.3	NULL
M	NULL
KCl	NULL
,	NULL
left	NULL
5	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
again	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
diluted	NULL
with	NULL
three	NULL
volumes	NULL
of	NULL
Tris-X	NULL
buffer	NULL
(	NULL
to	NULL
make	NULL
0.085	NULL
M	NULL
KCl	NULL
final	NULL
)	NULL
,	NULL
and	NULL
centrifuged	NULL
again	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
nuclear	NULL
extract	NULL
was	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Bacterially	NULL
expressed	NULL
,	NULL
purified	NULL
rat	NULL
C/EBP	NULL
(	NULL
rC/EBP/3	NULL
)	NULL
and	NULL
rat	NULL
C/EBPa	NULL
(	NULL
rC/EBPa	NULL
)	NULL
proteins	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
P.	NULL
Johnson	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Bacterially	NULL
expressed	NULL
human	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
Corp.	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

The	NULL
methods	NULL
for	NULL
radiolabeling	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
probes	NULL
using	NULL
Klenow	NULL
polymerase	NULL
and	NULL
[	NULL
a-	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
and	NULL
for	NULL
performing	NULL
the	NULL
EMSAs	NULL
have	NULL
been	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
antibodies	NULL
or	NULL
excess	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
proteins	NULL
or	NULL
nuclear	NULL
extracts	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
before	NULL
electrophoresis	NULL
on	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Antibodies	NULL
spe-	NULL
1450	NULL
_	NULL
R.	NULL
M.	NULL
Pope	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Ness	NULL
cific	NULL
for	NULL
cC/EBP/3	NULL
,	NULL
and	NULL
were	NULL
obtained	NULL
from	NULL
S.	NULL
Akira	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
and	NULL
P.	NULL
Johnson	NULL
,	NULL
respectively	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
.	NULL

The	NULL
following	NULL
synthetic	NULL
oligonucleotides	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
-130/+35	NULL
TNFa	NULL
radiolabeled	NULL
EMSA	NULL
probe	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
:	NULL
forward	NULL
,	NULL
5-GGCCCACTACCG-	NULL
``	NULL
;	NULL
reverse	NULL
,	NULL
5-CCTCTGCTGTCCTTGCTGA-3	NULL
'	NULL
.	NULL

The	NULL
following	NULL
radiolabeled	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
EMSAs	NULL
:	NULL
the	NULL
-100/-74	NULL
C/EBPG	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
,	NULL
5'-TCG-ACATGGGTTTCTCCACCAAGGAAGTTTTC-3	NULL
'	NULL
,	NULL
3'-GTACCCAA-AGAGGTGGTTCCTTCAAAAGAGCT-5	NULL
'	NULL
,	NULL
the	NULL
binding	NULL
sequence	NULL
from	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
24	NULL
)	NULL
,	NULL
5'-TCGAGACATTGCACA-ATCTG-3	NULL
'	NULL
,	NULL
3'-CTGTAACGTCTTAGACAGCT-5	NULL
'	NULL
,	NULL
and	NULL
the	NULL
Ig/HIV	NULL
promoter	NULL
binding	NULL
sequence	NULL
for	NULL
NF-kB	NULL
(	NULL
37	NULL
)	NULL
,	NULL
5'-TCGAGAAGGGAC-TTTCCGCTGGGGACTTTCCAGGGC-3	NULL
'	NULL
,	NULL
3'-CTTCCCTGAAAGG-CGACCCCTGAAAGGTCCCGAGCT-5	NULL
'	NULL
.	NULL

DNasel	NULL
footprinting	NULL
.	NULL

The	NULL
-615	NULL
TNFa-luciferase	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
Xhol	NULL
,	NULL
radiolabeled	NULL
by	NULL
end-filling	NULL
using	NULL
Klenow	NULL
polymerase	NULL
and	NULL
{	NULL
a-	NULL
P	NULL
]	NULL
dCTP	NULL
,	NULL
and	NULL
then	NULL
further	NULL
digested	NULL
with	NULL
HindIH	NULL
.	NULL

The	NULL
resulting	NULL
fragment	NULL
containing	NULL
the	NULL
TNFa	NULL
promoter	NULL
was	NULL
purified	NULL
after	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
using	NULL
Geneclean	NULL
(	NULL
Bio101	NULL
)	NULL
and	NULL
subjected	NULL
to	NULL
DNasel	NULL
footprinting	NULL
as	NULL
described	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Results	NULL
C/EBPG	NULL
activates	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

The	NULL
TNFa	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
strongly	NULL
activated	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
(	NULL
15	NULL
,	NULL
22	NULL
)	NULL
,	NULL
an	NULL
activator	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
which	NULL
also	NULL
activates	NULL
activity	NULL
(	NULL
31	NULL
,	NULL
39	NULL
)	NULL
.	NULL

We	NULL
used	NULL
transient	NULL
transfection	NULL
assays	NULL
to	NULL
determine	NULL
whether	NULL
C/EBPS	NULL
could	NULL
cooperate	NULL
with	NULL
PMA	NULL
treatment	NULL
to	NULL
activate	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

We	NULL
chose	NULL
the	NULL
Jurkat	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
normally	NULL
does	NULL
not	NULL
express	NULL
either	NULL
C/EBPS3	NULL
or	NULL
TNFa	NULL
,	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
in	NULL
our	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
series	NULL
of	NULL
TNFa	NULL
promoter-luciferase	NULL
reporter	NULL
gene	NULL
constructs	NULL
,	NULL
containing	NULL
portions	NULL
of	NULL
the	NULL
promoter	NULL
extending	NULL
from	NULL
just	NULL
downstream	NULL
to	NULL
several	NULL
hundred	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
22	NULL
)	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
either	NULL
with	NULL
a	NULL
control	NULL
plasmid	NULL
or	NULL
with	NULL
a	NULL
plasmid	NULL
expressing	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
constitutive	NULL
CMV	NULL
promoter	NULL
.	NULL

Parallel	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
and	NULL
without	NULL
PMA	NULL
treatment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
none	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
constructs	NULL
were	NULL
expressed	NULL
at	NULL
significant	NULL
levels	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
treatment	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hC/EBP/3	NULL
,	NULL
and	NULL
none	NULL
were	NULL
significantly	NULL
activated	NULL
by	NULL
PMA	NULL
treatment	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
expressing	NULL
led	NULL
to	NULL
strong	NULL
activation	NULL
of	NULL
all	NULL
but	NULL
the	NULL
shortest	NULL
promoter	NULL
constructs	NULL
tested	NULL
(	NULL
-36	NULL
bp	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
PMA	NULL
and	NULL
C/EBP/3	NULL
acted	NULL
cooperatively	NULL
to	NULL
induce	NULL
TNFa	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
crucial	NULL
PMA-	NULL
and	NULL
C/EBP	NULL
/3-responsive	NULL
elements	NULL
must	NULL
lie	NULL
in	NULL
the	NULL
region	NULL
bounded	NULL
by	NULL
positions	NULL
-95	NULL
and	NULL
-36	NULL
in	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

The	NULL
promoter	NULL
construct	NULL
extending	NULL
only	NULL
to	NULL
position	NULL
-95	NULL
was	NULL
consistently	NULL
less	NULL
active	NULL
than	NULL
the	NULL
longer	NULL
versions	NULL
(	NULL
-120	NULL
and	NULL
-295	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
important	NULL
regulatory	NULL
element	NULL
(	NULL
s	NULL
)	NULL
might	NULL
lie	NULL
near	NULL
the	NULL
-95	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

C/EBPG	NULL
binds	NULL
a	NULL
specific	NULL
site	NULL
in	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
above	NULL
suggested	NULL
that	NULL
could	NULL
regulate	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

An	NULL
EMSA	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
promoter	NULL
contained	NULL
a	NULL
bona	NULL
fide	NULL
C/EBPS	NULL
binding	NULL
site	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
results	NULL
with	NULL
the	NULL
promoter-reporter	NULL
gene	NULL
constructs	NULL
(	NULL
see	NULL
above	NULL
)	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
radiolabeled	NULL
fragment	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
bounded	NULL
by	NULL
positions	NULL
-	NULL
130	NULL
to	NULL
+35	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
A	NULL
shows	NULL
an	NULL
EMSA	NULL
experiment	NULL
in	NULL
which	NULL
such	NULL
an	NULL
oligonucleotide	NULL
was	NULL
efficiently	NULL
bound	NULL
-36	NULL
Q0	NULL
Figure	NULL
1.	NULL
activates	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

Transfections	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
,	NULL
using	NULL
0.5	NULL
ug	NULL
of	NULL
the	NULL
hC/EBPS3	NULL
plasmid	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
TNFa	NULL
promoter	NULL
reporter	NULL
construct	NULL
.	NULL

On	NULL
the	NULL
left	NULL
of	NULL
the	NULL
bar	NULL
graphs	NULL
are	NULL
diagrammed	NULL
the	NULL
TNFa	NULL
reporter-lu-ciferase	NULL
constructs	NULL
used	NULL
.	NULL

Potential	NULL
binding	NULL
sites	NULL
for	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
indicated	NULL
by	NULL
labeled	NULL
boxes	NULL
.	NULL

The	NULL
relative	NULL
light	NULL
units	NULL
have	NULL
been	NULL
corrected	NULL
for	NULL
the	NULL
C/EBPB	NULL
Only	NULL
PMA	NULL
Only	NULL
H	NULL
C/EBPB+PMA	NULL
by	NULL
insect	NULL
cell-expressed	NULL
chicken	NULL
(	NULL
cC/EBPS3	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
inhibited	NULL
completely	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
C/EBPS3-binding	NULL
site	NULL
from	NULL
the	NULL
human	NULL
IL-6	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
antibodies	NULL
specific	NULL
for	NULL
cC/	NULL
EBP/3	NULL
resulted	NULL
in	NULL
a	NULL
``	NULL
'supershift'*	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
binding	NULL
reac-	NULL
Figure	NULL
2	NULL
.	NULL

C/EBPG	NULL
binds	NULL
A	NULL
to	NULL
the	NULL
human	NULL
TNFa	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
of	NULL
C/	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
EBP	NULL
to	NULL
the	NULL
-130/+35	NULL
TNFa	NULL
promoter	NULL
oligonu-	NULL
cleotide	NULL
.	NULL

Lanes	NULL
1-5	NULL
rep	NULL
i	NULL
-	NULL
dk	NULL
resent	NULL
increasing	NULL
quanti-	NULL
*	NULL
a	NULL
‘	NULL
ties	NULL
(	NULL
0.5-3	NULL
wl	NULL
)	NULL
of	NULL
cC/	NULL
--	NULL
€€€	NULL
EBP	NULL
,	NULL
which	NULL
was	NULL
expressed	NULL
in	NULL
Baculovirus-infected	NULL
insect	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
free	NULL
and	NULL
C/	NULL
EBP	NULL
/3-bound	NULL
oligonucleotides	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNasel	NULL
footprinting	NULL
R	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

“	NULL
Binding	NULL
and	NULL
footprint	NULL
re	NULL
named	NULL
Free	NULL
actions	NULL
are	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

The	NULL
lanes	NULL
that	NULL
B	NULL
received	NULL
the	NULL
THP-1	NULL
nu-Nuc	NULL
Extract	NULL
-	NULL
=	NULL
to	NULL
+o	NULL
+	NULL
clear	NULL
extracts	NULL
(	NULL
Nuc	NULL
!	NULL

.	NULL

Ex-Antiserum	NULL
:	NULL
=	NULL
=	NULL
I	NULL
N	NULL
tract	NULL
)	NULL
,	NULL
the	NULL
immune	NULL
anti-hC/EBPS3	NULL
(	NULL
1	NULL
)	NULL
,	NULL
or	NULL
control	NULL
nonimmune	NULL
serum	NULL
(	NULL
N	NULL
)	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
-102	NULL
and	NULL
-84	NULL
represent	NULL
the	NULL
base	NULL
pair	NULL
distance	NULL
5	NULL
'	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
determined	NULL
using	NULL
size	NULL
standards	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
DNaselI	NULL
hypersensitive	NULL
site	NULL
,	NULL
located	NULL
at	NULL
-90	NULL
bp	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
is	NULL
identified	NULL
by	NULL
the	NULL
arrow	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Bound	NULL
”	NULL
wwMiMV	NULL
'	NULL
1s	NULL
-2	NULL
8	NULL
-~4	NULL
Promoter	NULL
Activity	NULL
(	NULL
Relative	NULL
Light	NULL
Units	NULL
x	NULL
10	NULL
``	NULL
)	NULL
total	NULL
protein	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
in	NULL
>	NULL
10	NULL
experiments	NULL
and	NULL
with	NULL
different	NULL
plasmid	NULL
preparations	NULL
.	NULL

1	NULL
200	NULL
300	NULL
400	NULL
tion	NULL
.	NULL

Similar	NULL
complexes	NULL
were	NULL
also	NULL
formed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
human	NULL
myeloid	NULL
cell	NULL
line	NULL
THP-1	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
C/EBPS	NULL
could	NULL
play	NULL
a	NULL
direct	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

A	NULL
DNaselI	NULL
footprint	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
more	NULL
precisely	NULL
localize	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
C/EBP/	NULL
on	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
to	NULL
an	NULL
end-labeled	NULL
fragment	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
new	NULL
DNaselI	NULL
hypersensitive	NULL
site	NULL
at	NULL
position	NULL
-90	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
,	NULL
rather	NULL
than	NULL
a	NULL
discrete	NULL
protected	NULL
region	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
extracts	NULL
contained	NULL
a	NULL
protein	NULL
or	NULL
complex	NULL
that	NULL
specifically	NULL
interacted	NULL
with	NULL
this	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Addition	NULL
of	NULL
antibodies	NULL
specific	NULL
for	NULL
hC/EBP/3	NULL
,	NULL
but	NULL
not	NULL
nonimmune	NULL
serum	NULL
,	NULL
blocked	NULL
the	NULL
hypersensitive	NULL
site	NULL
formation	NULL
,	NULL
indicating	NULL
that	NULL
C/EBP/3	NULL
,	NULL
or	NULL
a	NULL
protein	NULL
complex	NULL
containing	NULL
was	NULL
responsible	NULL
for	NULL
this	NULL
change	NULL
in	NULL
the	NULL
DNasel	NULL
sensitivity	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Two	NULL
potential	NULL
C/EBP/	NULL
{	NULL
3-binding	NULL
sites	NULL
,	NULL
in	NULL
opposite	NULL
orienta-tions	NULL
,	NULL
were	NULL
noted	NULL
extending	NULL
from	NULL
-97	NULL
to	NULL
-79	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
,	NULL
which	NULL
conformed	NULL
at	NULL
9	NULL
of	NULL
12	NULL
positions	NULL
to	NULL
the	NULL
consensus	NULL
C/EBP/3-binding	NULL
site	NULL
,	NULL
T	NULL
(	NULL
T/	NULL
G	NULL
)	NULL
NNGNAA	NULL
(	NULL
T/G	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
insect	NULL
cell-expressed	NULL
S3	NULL
protein	NULL
bound	NULL
efficiently	NULL
to	NULL
a	NULL
radiolabeled	NULL
,	NULL
synthetic	NULL
26-mer	NULL
oligonucleotide	NULL
containing	NULL
this	NULL
site	NULL
.	NULL

Again	NULL
,	NULL
C/	NULL
EBPA	NULL
binding	NULL
was	NULL
inhibited	NULL
completely	NULL
when	NULL
an	NULL
excess	NULL
of	NULL
either	NULL
unlabeled	NULL
oligonucleotide	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
or	NULL
one	NULL
containing	NULL
a	NULL
previously	NULL
identified	NULL
C/EBPA-binding	NULL
site	NULL
from	NULL
the	NULL
human	NULL
IL-6	NULL
gene	NULL
promoter	NULL
was	NULL
included	NULL
.	NULL

The	NULL
complex	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
an	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
Ig/HIV	NULL
promoter	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
even	NULL
though	NULL
the	NULL
oligonucleotide	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
contained	NULL
a	NULL
previously	NULL
characterized	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
17	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
antibodies	NULL
specific	NULL
for	NULL
cC/EBP/3	NULL
,	NULL
but	NULL
not	NULL
control	NULL
antibodies	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
protein-DNA	NULL
com-plex	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
also	NULL
been	NULL
obtained	NULL
using	NULL
recombinant	NULL
,	NULL
purified	NULL
rat	NULL
C/EBPS	NULL
(	NULL
rC/EBP3	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
C/EBP/3	NULL
bound	NULL
quite	NULL
efficiently	NULL
to	NULL
the	NULL
TNFa	NULL
pro-moter-derived	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
IL-6	NULL
promoter	NULL
was	NULL
a	NULL
better	NULL
competitor	NULL
when	NULL
the	NULL
-100/-74	NULL
TNFa	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
TNFa	NULL
promoter	NULL
was	NULL
relatively	NULL
weak	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
C/EBP/3	NULL
regulates	NULL
the	NULL
human	NULL
TNFa	NULL
gene	NULL
pro	NULL
C/EBP	NULL
B	NULL
Regulates	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Expression	NULL
1451	NULL
Figure	NULL
3	NULL
.	NULL

Binding	NULL
of	NULL
cC/	NULL
EBP	NULL
to	NULL
the	NULL
-100/-74	NULL
human	NULL
TNFa	NULL
promoter	NULL
oligonucleotide	NULL
.	NULL

The	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
Baculovirus-ex-pressed	NULL
cC/EBP/3	NULL
and	NULL
with	NULL
the	NULL
radiolabeled	NULL
-100/-74	NULL
TNFa	NULL
promoter	NULL
oligonucleotide	NULL
.	NULL

|	NULL
_	NULL
The	NULL
competitors	NULL
included	NULL
\_	NULL
an	NULL
unlabeled	NULL
,	NULL
irrelevant	NULL
,	NULL
control	NULL
oligonucleotide	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
unlabeled	NULL
oligonucleotides	NULL
representing	NULL
the	NULL
C/EBP3-binding	NULL
site	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
IL-6	NULL
)	NULL
and	NULL
that	NULL
used	NULL
as	NULL
the	NULL
radiolabeled	NULL
probe	NULL
(	NULL
TNF	NULL
)	NULL
(	NULL
lanes	NULL
I-4	NULL
}	NULL
.	NULL

These	NULL
competitors	NULL
were	NULL
used	NULL
at	NULL
50-	NULL
or	NULL
500-fold	NULL
excess	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Nonimmune	NULL
(	NULL
N	NULL
)	NULL
or	NULL
immune	NULL
A	NULL
(	NULL
I	NULL
)	NULL
,	NULL
anti-cC/EBP/3	NULL
,	NULL
rab-Free	NULL
*a	NULL
bit	NULL
antisera	NULL
were	NULL
included	NULL
where	NULL
indicated	NULL
1.2	NULL
3	NULL
4	NULL
5.6	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

____Competitors	NULL
___	NULL
era	NULL
C	NULL
IL-6	NULL
TNF	NULL
TNF	NULL
_	NULL
N	NULL
I	NULL
50x	NULL
50x	NULL
50x	NULL
500	NULL
%	NULL
Bound	NULL
moter	NULL
by	NULL
binding	NULL
directly	NULL
to	NULL
a	NULL
specific	NULL
site	NULL
and	NULL
activating	NULL
its	NULL
transcription	NULL
.	NULL

Selectivity	NULL
of	NULL
binding	NULL
to	NULL
-100/-74	NULL
TNFa	NULL
oligonucleotide	NULL
.	NULL

and	NULL
C/EBPa	NULL
are	NULL
both	NULL
expressed	NULL
in	NULL
macrophage	NULL
cell	NULL
lines	NULL
and	NULL
are	NULL
capable	NULL
of	NULL
heterodimerization	NULL
and	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
oligonucleotides	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
C/EBPa	NULL
and	NULL
C/EBP	NULL
to	NULL
interact	NULL
differently	NULL
with	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

Using	NULL
an	NULL
EMSA	NULL
,	NULL
purified	NULL
recombinant	NULL
C/	NULL
EBP/	NULL
#	NULL
and	NULL
C/EBPa	NULL
both	NULL
bound	NULL
strongly	NULL
to	NULL
the	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Binding	NULL
by	NULL
both	NULL
isoforms	NULL
to	NULL
the	NULL
IL-6	NULL
probe	NULL
was	NULL
inhibited	NULL
by	NULL
excess	NULL
unlabeled	NULL
IL-6	NULL
,	NULL
but	NULL
not	NULL
TNFa	NULL
,	NULL
promoter	NULL
oligonucleotide	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
observed	NULL
previously	NULL
with	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
cMGF	NULL
promoter	NULL
(	NULL
31	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
only	NULL
C/EBPS	NULL
bound	NULL
to	NULL
the	NULL
-100/-74	NULL
TNFa	NULL
oligonucleotide	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
site	NULL
was	NULL
specific	NULL
for	NULL
only	NULL
one	NULL
member	NULL
of	NULL
this	NULL
highly	NULL
related	NULL
family	NULL
of	NULL
bZip	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

A	NULL
cotransfection	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
test	NULL
whether	NULL
both	NULL
bZip	NULL
proteins	NULL
could	NULL
activate	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
TNFa	NULL
or	NULL
cMGF	NULL
promoter-reporter	NULL
constructs	NULL
,	NULL
plus	NULL
either	NULL
C/EBPS3	NULL
or	NULL
C/EBPa	NULL
expression	NULL
vectors	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
PMA	NULL
.	NULL

Both	NULL
transcription	NULL
factors	NULL
activated	NULL
the	NULL
cMGF	NULL
promoter	NULL
to	NULL
approximately	NULL
equal	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
C/EBPS	NULL
was	NULL
a	NULL
stronger	NULL
activator	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
than	NULL
C/EBPa	NULL
,	NULL
consistent	NULL
with	NULL
its	NULL
stronger	NULL
binding	NULL
in	NULL
the	NULL
EMSA	NULL
.	NULL

When	NULL
C/EBPa	NULL
was	NULL
coex-pressed	NULL
with	NULL
C/EBP/3	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
observed	NULL
with	NULL
C/EBP	NULL
alone	NULL
,	NULL
suggesting	NULL
either	NULL
that	NULL
C/EBPa//	NULL
#	NULL
heterodimers	NULL
were	NULL
as	NULL
active	NULL
as	NULL
C/EBPS	NULL
homodimers	NULL
or	NULL
that	NULL
was	NULL
somehow	NULL
dominant	NULL
.	NULL

Dominant-negative	NULL
C/EBPG	NULL
inhibits	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

Overexpression	NULL
of	NULL
could	NULL
affect	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
in	NULL
two	NULL
ways	NULL
,	NULL
either	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
promoter	NULL
1452	NULL
-	NULL
R.	NULL
M.	NULL
Pope	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Ness	NULL
and	NULL
directly	NULL
activating	NULL
its	NULL
transcription	NULL
or	NULL
by	NULL
interfering	NULL
with	NULL
negative-regulatory	NULL
effects	NULL
of	NULL
other	NULL
bZip	NULL
proteins	NULL
such	NULL
as	NULL
C/	NULL
EBPa	NULL
,	NULL
perhaps	NULL
by	NULL
forming	NULL
inactive	NULL
heterodimers	NULL
(	NULL
42	NULL
)	NULL
.	NULL

This	NULL
was	NULL
tested	NULL
using	NULL
a	NULL
truncated	NULL
,	NULL
dominant-negative	NULL
(	NULL
DN	NULL
)	NULL
version	NULL
of	NULL
the	NULL
chick	NULL
C/EBP/3	NULL
protein	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
,	NULL
termed	NULL
DN229	NULL
.	NULL

This	NULL
version	NULL
of	NULL
C/EBP/	NULL
only	NULL
contains	NULL
the	NULL
COOH-terminal	NULL
229-most	NULL
amino	NULL
acids	NULL
.	NULL

It	NULL
therefore	NULL
lacks	NULL
the	NULL
transactivation	NULL
domain	NULL
,	NULL
leaving	NULL
the	NULL
dimerization	NULL
and	NULL
DNA-binding	NULL
domains	NULL
intact	NULL
.	NULL

It	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
DNA	NULL
,	NULL
but	NULL
has	NULL
no	NULL
transactivation	NULL
activity	NULL
,	NULL
and	NULL
forms	NULL
inactive	NULL
heterodimers	NULL
with	NULL
other	NULL
C/EBP	NULL
-like	NULL
proteins	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
DN229	NULL
construct	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
quite	NULL
effective	NULL
at	NULL
suppressing	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
C/EBP	NULL
#	NULL
-regulated	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
cMGF	NULL
and	NULL
mim-1	NULL
genes	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

When	NULL
compared	NULL
with	NULL
control	NULL
expression	NULL
vectors	NULL
without	NULL
an	NULL
insert	NULL
,	NULL
cotransfection	NULL
of	NULL
the	NULL
DN229	NULL
plasmid	NULL
was	NULL
quite	NULL
effective	NULL
at	NULL
inhibiting	NULL
the	NULL
ability	NULL
of	NULL
hC/EBPS	NULL
to	NULL
activate	NULL
the	NULL
TNFa	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
even	NULL
though	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
DN229	NULL
construct	NULL
is	NULL
not	NULL
only	NULL
unable	NULL
to	NULL
activate	NULL
the	NULL
TNFa	NULL
promoter	NULL
,	NULL
but	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
C/EBP	NULL
blocks	NULL
activation	NULL
by	NULL
the	NULL
full-length	NULL
protein	NULL
.	NULL

A	NULL
similar	NULL
experiment	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
human	NULL
mye-lomonocyte	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
which	NULL
expresses	NULL
endogenous	NULL
C/	NULL
EBP/3	NULL
protein	NULL
and	NULL
secretes	NULL
a	NULL
high	NULL
concentration	NULL
of	NULL
TNFa	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
to	NULL
determine	NULL
whether	NULL
ectopi-cally	NULL
expressed	NULL
DN229	NULL
could	NULL
likewise	NULL
block	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
shows	NULL
that	NULL
the	NULL
TNFa	NULL
promoter	NULL
construct	NULL
extending	NULL
to	NULL
position	NULL
-120	NULL
,	NULL
the	NULL
construct	NULL
that	NULL
consistently	NULL
provided	NULL
the	NULL
greatest	NULL
activation	NULL
,	NULL
was	NULL
moderately	NULL
active	NULL
when	NULL
transfected	NULL
into	NULL
U937	NULL
cells	NULL
and	NULL
that	NULL
its	NULL
expression	NULL
was	NULL
stimulated	NULL
three-	NULL
to	NULL
fivefold	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
.	NULL

(	NULL
Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
other	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
human	NULL
THP-1	NULL
and	NULL
chicken	NULL
HD-11	NULL
cells	NULL
.	NULL
)	NULL

Expression	NULL
of	NULL
the	NULL
dominant-negative	NULL
form	NULL
of	NULL
C/EBP3	NULL
(	NULL
DN229	NULL
)	NULL
not	NULL
only	NULL
blocked	NULL
activation	NULL
by	NULL
PMA	NULL
,	NULL
but	NULL
also	NULL
inhibited	NULL
TNFa	NULL
promoter	NULL
activity	NULL
to	NULL
below	NULL
basal	NULL
levels	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
control	NULL
plasmid	NULL
containing	NULL
only	NULL
the	NULL
CMV	NULL
promoter	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
TNFa	NULL
promoter-reporter	NULL
gene	NULL
construct	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
human	NULL
TNFa	NULL
promoter	NULL
is	NULL
directly	NULL
regulated	NULL
by	NULL
C/EBP/	NULL
#	NULL
3	NULL
,	NULL
most	NULL
probably	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
region	NULL
between	NULL
-95	NULL
and	NULL
-36	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
Site	NULL
.	NULL

Discussion	NULL
Activation	NULL
of	NULL
TNFa	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
responses	NULL
to	NULL
inflammatory	NULL
and	NULL
infectious	NULL
agents	NULL
,	NULL
and	NULL
it	NULL
is	NULL
known	NULL
to	NULL
be	NULL
highly	NULL
expressed	NULL
by	NULL
activated	NULL
macrophages	NULL
,	NULL
such	NULL
as	NULL
those	NULL
found	NULL
in	NULL
the	NULL
synovial	NULL
lining	NULL
of	NULL
rheumatoid	NULL
joints	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
results	NULL
in	NULL
this	NULL
paper	NULL
demonstrate	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
C/	NULL
EBP	NULL
#	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
the	NULL
TNFa	NULL
gene	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
specific	NULL
site	NULL
in	NULL
the	NULL
TNFa	NULL
promoter	NULL
,	NULL
shown	NULL
that	NULL
the	NULL
promoter	NULL
responds	NULL
dramatically	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
C/	NULL
EBP	NULL
}	NULL
,	NULL
and	NULL
used	NULL
a	NULL
dominant-negative	NULL
version	NULL
of	NULL
C/EBP	NULL
#	NULL
to	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

The	NULL
C/EBP/3-binding	NULL
site	NULL
identified	NULL
by	NULL
DNasel	NULL
footprinting	NULL
and	NULL
EMSA	NULL
experiments	NULL
maps	NULL
to	NULL
positions	NULL
~100/-74	NULL
of	NULL
the	NULL
human	NULL
TNFa	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
oligonucleotide	NULL
from	NULL
the	NULL
IL-6	NULL
promoter	NULL
,	NULL
C/EBP	NULL
#	NULL
bound	NULL
the	NULL
-100/	NULL
-74	NULL
site	NULL
relatively	NULL
weakly	NULL
.	NULL

Nevertheless	NULL
,	NULL
in	NULL
DNasel	NULL
footprinting	NULL
assays	NULL
,	NULL
which	NULL
are	NULL
generally	NULL
much	NULL
less	NULL
sensitive	NULL
than	NULL
EMSAs	NULL
,	NULL
myeloid	NULL
cell	NULL
extracts	NULL
induced	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
DNasel	NULL
hypersensitive	NULL
site	NULL
on	NULL
the	NULL
TNFa	NULL
promoter	NULL
at	NULL
position	NULL
-90	NULL
,	NULL
A	NULL
Lane	NULL
:	NULL
_1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
°~6	NULL
7	NULL
8	NULL
9	NULL
C/EBPB	NULL
+	NULL
+	NULL
=	NULL
=	NULL
_.®	NULL
=~	NULL
+	NULL
+	NULL
+	NULL
C/EBPa	NULL
=	NULL
=	NULL
.+	NULL
$	NULL
$	NULL
o	NULL
$	NULL
%	NULL
'	NULL
-	NULL
®	NULL
Probe	NULL
:	NULL
TNF	NULL
TNF	NULL
TNF	NULL
IL6	NULL
IL6	NULL
IL6	NULL
IL6	NULL
IL6	NULL
IL6	NULL
Competitor	NULL
:	NULL
C	NULL
C	NULL
C	NULL
C	NULL
IL6	NULL
TNF	NULL
C	NULL
TNF	NULL
IL6	NULL
Sera	NULL
:	NULL
N	NULL
1	NULL
=	NULL
&	NULL
HET	NULL
]	NULL
NL	NULL
ei	NULL
C/EBPo	NULL
u	NULL
C/EBPB	NULL
N	NULL
UJ	NULL
1007	NULL
Promoter	NULL
Activation	NULL
(	NULL
Fold	NULL
Increase	NULL
)	NULL
Free	NULL
TNFa-luc	NULL
+	NULL
C/EBPB	NULL
TNFa-uc	NULL
+	NULL
Both	NULL
TNFoAuc	NULL
+	NULL
C/EBPa	NULL
0.5	NULL
1	NULL
1.5	NULL
2	NULL
C/EBP	NULL
Expression	NULL
Vector	NULL
(	NULL
ug	NULL
transfected	NULL
)	NULL
Figure	NULL
4	NULL
.	NULL

The	NULL
TNFa	NULL
promoter	NULL
is	NULL
specific	NULL
for	NULL
C/EBP	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Selective	NULL
binding	NULL
of	NULL
C/EBP	NULL
,	NULL
but	NULL
not	NULL
C/EBPa	NULL
,	NULL
to	NULL
the	NULL
-100/-74	NULL
TNFa	NULL
promoter	NULL
.	NULL

The	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
recombinant	NULL
,	NULL
purified	NULL
rC/EBPa	NULL
(	NULL
lanes	NULL
3-6	NULL
)	NULL
and	NULL
rC/EBPS	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
7-9	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
radiolabeled	NULL
probes	NULL
,	NULL
which	NULL
included	NULL
the	NULL
C/EBP	NULL
-binding	NULL
site	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
IL-6	NULL
)	NULL
and	NULL
the	NULL
-100/-74	NULL
TNFa	NULL
promoter	NULL
(	NULL
TNF	NULL
)	NULL
oligonucleotides	NULL
,	NULL
and	NULL
the	NULL
competitor	NULL
oligonucleotides	NULL
,	NULL
used	NULL
at	NULL
100-fold	NULL
excess	NULL
,	NULL
are	NULL
also	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
(	NULL
symbols	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Nonimmune	NULL
(	NULL
N	NULL
)	NULL
or	NULL
monospecific	NULL
,	NULL
immune	NULL
anti-rC/EBPS	NULL
(	NULL
7	NULL
)	NULL
sera	NULL
were	NULL
added	NULL
where	NULL
indicated	NULL
.	NULL

The	NULL
mobilities	NULL
of	NULL
the	NULL
C/EBPa	NULL
and	NULL
C/EBP/3	NULL
bound	NULL
and	NULL
the	NULL
free	NULL
,	NULL
unbound	NULL
radiolabeled	NULL
-100/-74	NULL
TNFa	NULL
oligonucleotide	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

(	NULL
B	NULL
)	NULL
C/EBP/3	NULL
preferentially	NULL
activates	NULL
the	NULL
TNFa	NULL
promoter	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

They	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
TNFo-luciferase	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
or	NULL
with	NULL
cMGF-luciferase	NULL
(	NULL
4.5	NULL
ug	NULL
)	NULL
constructs	NULL
and	NULL
with	NULL
the	NULL
hC/EBPS	NULL
or	NULL
the	NULL
rC/EBPa	NULL
expression	NULL
vectors	NULL
in	NULL
the	NULL
concentrations	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
both	NULL
C/EBPa	NULL
and	NULL
C/EBP	NULL
#	NULL
3	NULL
were	NULL
cotransfected	NULL
at	NULL
equal	NULL
concentrations	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
represents	NULL
the	NULL
fold	NULL
increase	NULL
over	NULL
baseline	NULL
induced	NULL
by	NULL
PMA	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
repeated	NULL
twice	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

and	NULL
this	NULL
activity	NULL
was	NULL
inhibited	NULL
by	NULL
antisera	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
nuclear	NULL
extract	NULL
,	NULL
the	NULL
C/EBP/3	NULL
appears	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
relatively	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
factor	NULL
may	NULL
be	NULL
part	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
which	NULL
binds	NULL
the	NULL
TNFa	NULL
promoter	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
TNFa	NULL
promoter	NULL
was	NULL
differentially	NULL
recognized	NULL
by	NULL
C/	NULL
EBP	NULL
}	NULL
and	NULL
C/EBPa	NULL
.	NULL

Purified	NULL
recombinant	NULL
C/EBP/	NULL
,	NULL
but	NULL
not	NULL
C/	NULL
EBPa	NULL
,	NULL
bound	NULL
to	NULL
the	NULL
TNFa	NULL
promoter	NULL
oligonucleotide	NULL
in	NULL
EMSA	NULL
assays	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
difference	NULL
,	NULL
C/EBP/3	NULL
was	NULL
considerably	NULL
more	NULL
active	NULL
than	NULL
C/EBPa	NULL
at	NULL
activating	NULL
the	NULL
TNFa	NULL
promoter	NULL
construct	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
cMGF	NULL
promoter	NULL
,	NULL
which	NULL
readily	NULL
binds	NULL
both	NULL
C/EBP	NULL
proteins	NULL
,	NULL
was	NULL
activated	NULL
equally	NULL
well	NULL
by	NULL
each	NULL
.	NULL

Both	NULL
C/EBPa	NULL
and	NULL
are	NULL
expressed	NULL
in	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
,	NULL
however	NULL
,	NULL
C/EBPa	NULL
decreased	NULL
while	NULL
increased	NULL
with	NULL
differentiation	NULL
and	NULL
activation	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
differential	NULL
binding	NULL
of	NULL
the	NULL
two	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
TNFa	NULL
in	NULL
monocytes/	NULL
macrophages	NULL
where	NULL
both	NULL
bZip	NULL
proteins	NULL
are	NULL
expressed	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
region	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
that	NULL
contains	NULL
the	NULL
C/EBP/3-binding	NULL
site	NULL
(	NULL
at	NULL
position	NULL
-90	NULL
)	NULL
has	NULL
also	NULL
been	NULL
noted	NULL
by	NULL
others	NULL
.	NULL

For	NULL
example	NULL
,	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
43-nucleo-tide-long	NULL
fragment	NULL
of	NULL
the	NULL
promoter	NULL
spanning	NULL
this	NULL
site	NULL
was	NULL
suffi-	NULL
cient	NULL
to	NULL
confer	NULL
both	NULL
elevated	NULL
basal	NULL
and	NULL
TNFa-inducible	NULL
activity	NULL
to	NULL
an	NULL
otherwise	NULL
minimally	NULL
active	NULL
heterologous	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
a	NULL
cyclosporin	NULL
A-	NULL
and	NULL
FK506-sensitive	NULL
factor	NULL
in	NULL
the	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
Ar-5	NULL
was	NULL
identified	NULL
that	NULL
functions	NULL
through	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
promoter	NULL
overlapping	NULL
the	NULL
C/EBP/3-binding	NULL
site	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
the	NULL
-90	NULL
site	NULL
is	NULL
adjacent	NULL
to	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
17	NULL
,	NULL
24	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
C/EBPS	NULL
$	NULL
in	NULL
vitro	NULL
(	NULL
26	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
C/EBP/3	NULL
and	NULL
NF-kB	NULL
bound	NULL
to	NULL
the	NULL
IL-6	NULL
and	NULL
the	NULL
IL-8	NULL
gene	NULL
promoters	NULL
,	NULL
and	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
two	NULL
factors	NULL
appeared	NULL
to	NULL
regulate	NULL
the	NULL
activities	NULL
of	NULL
those	NULL
genes	NULL
(	NULL
34	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Our	NULL
own	NULL
preliminary	NULL
data	NULL
suggest	NULL
that	NULL
overexpression	NULL
of	NULL
NF-	NULL
«	NULL
BI1	NULL
or	NULL
RelA	NULL
may	NULL
inhibit	NULL
C/EBP	NULL
ated	NULL
activation	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Pope	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Ness	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Further	NULL
work	NULL
will	NULL
be	NULL
required	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
interact	NULL
to	NULL
regulate	NULL
the	NULL
TNFa	NULL
gene	NULL
.	NULL

An	NULL
interesting	NULL
feature	NULL
of	NULL
TNFa	NULL
gene	NULL
regulation	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
its	NULL
apparent	NULL
dependence	NULL
on	NULL
both	NULL
C/EBP/3	NULL
and	NULL
PMA	NULL
treatment	NULL
,	NULL
which	NULL
presumably	NULL
participates	NULL
by	NULL
stimulating	NULL
protein	NULL
kinase	NULL
C.	NULL
PMA	NULL
treatment	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
lead	NULL
to	NULL
phosphorylation	NULL
of	NULL
C/EBP	NULL
,	NULL
induce	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
enhance	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
transcription	NULL
(	NULL
31	NULL
,	NULL
39	NULL
)	NULL
,	NULL
sug-	NULL
C/EBP	NULL
{	NULL
3	NULL
Regulates	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Expression	NULL
1453	NULL
\	NULL
--	NULL
C-	NULL
-95	NULL
TNF	NULL
&	NULL
u	NULL
2s1	NULL
3	NULL
,	NULL
--	NULL
O	NULL
--	NULL
-	NULL
120	NULL
TNFa	NULL
U	NULL
A	NULL
-A-	NULL
-295	NULL
TNFa	NULL
Percent	NULL
Inhibition	NULL
of	NULL
TNF	NULL
Activation	NULL
507	NULL
757	NULL
1m	NULL
I	NULL
t	NULL
I	NULL
I	NULL
0	NULL
0.5	NULL
1	NULL
1.5	NULL
2	NULL
Dominant	NULL
Negative	NULL
C/EBPB	NULL
(	NULL
ug	NULL
plasmid	NULL
transfected	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Dominant-negative	NULL
C/EBPS	NULL
inhibits	NULL
TNFa	NULL
promoter	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
except	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
TNFa	NULL
reporter	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
hC/EBPS	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
expression	NULL
plasmids	NULL
,	NULL
the	NULL
DN	NULL
C/EBPS3	NULL
(	NULL
DN229	NULL
)	NULL
or	NULL
vector	NULL
(	NULL
pCDMS8	NULL
)	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
in	NULL
the	NULL
indicated	NULL
quantities	NULL
.	NULL

Relative	NULL
light	NULL
units	NULL
were	NULL
corrected	NULL
for	NULL
the	NULL
total	NULL
protein	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
.	NULL

Percent	NULL
suppression	NULL
was	NULL
determined	NULL
by	NULL
comparison	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
repeated	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

gesting	NULL
that	NULL
PMA	NULL
treatment	NULL
may	NULL
be	NULL
required	NULL
simply	NULL
to	NULL
convert	NULL
the	NULL
over-expressed	NULL
to	NULL
a	NULL
more	NULL
active	NULL
form	NULL
.	NULL

Alterna-tively	NULL
,	NULL
PMA	NULL
may	NULL
activate	NULL
other	NULL
transcription	NULL
factors	NULL
which	NULL
cooperate	NULL
with	NULL
C/EBP/3	NULL
,	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
c-jun	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Several	NULL
potential	NULL
PMA-responsive	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
TNFa	NULL
promoter	NULL
,	NULL
including	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
AP-2	NULL
located	NULL
at	NULL
positions	NULL
-63	NULL
and	NULL
-34	NULL
,	NULL
respectively	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
c-jun	NULL
enhanced	NULL
and	NULL
mutation	NULL
of	NULL
the	NULL
AP-1-binding	NULL
site	NULL
diminished	NULL
TNFa	NULL
gene	NULL
expres-sion	NULL
,	NULL
supporting	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Whether	NULL
or	NULL
not	NULL
interaction	NULL
between	NULL
and	NULL
c-jun	NULL
is	NULL
important	NULL
in	NULL
Control	NULL
Control	NULL
+	NULL
PMA	NULL
Vector	NULL
+	NULL
PMA	NULL
DN229	NULL
+	NULL
PMA	NULL
F	NULL
T	NULL
T	NULL
T	NULL
1	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
Figure	NULL
6	NULL
.	NULL

PMA-induced	NULL
TNFa	NULL
promoter	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
is	NULL
inhibited	NULL
by	NULL
DN	NULL
C/EBP/3	NULL
.	NULL

The	NULL
transfections	NULL
were	NULL
performed	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
,	NULL
using	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
-	NULL
120	NULL
TNFa	NULL
reporter	NULL
construct	NULL
,	NULL
and	NULL
0.5	NULL
ug	NULL
of	NULL
the	NULL
DN	NULL
C/EBP	NULL
(	NULL
DN229	NULL
)	NULL
or	NULL
vector	NULL
(	NULL
pCDM	NULL
#	NULL
8	NULL
)	NULL
.	NULL

Relative	NULL
light	NULL
units	NULL
were	NULL
corrected	NULL
for	NULL
the	NULL
total	NULL
protein	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
repeated	NULL
four	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

1454	NULL
R.	NULL
M.	NULL
Pope	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Ness	NULL
TNFa	NULL
activation	NULL
(	NULL
49	NULL
)	NULL
,	NULL
and	NULL
whether	NULL
the	NULL
TNFa	NULL
gene	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
C/EBP/3	NULL
,	NULL
for	NULL
example	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
that	NULL
do	NULL
not	NULL
express	NULL
the	NULL
factor	NULL
,	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
TNFa	NULL
,	NULL
a	NULL
number	NULL
of	NULL
other	NULL
cytokine	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
MIP-1a	NULL
also	NULL
possess	NULL
functional	NULL
C/EBP/	NULL
{	NULL
3-binding	NULL
sites	NULL
in	NULL
their	NULL
promoters	NULL
(	NULL
24	NULL
,	NULL
30	NULL
,	NULL
32-35	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
are	NULL
considered	NULL
important	NULL
mediators	NULL
of	NULL
inflammation	NULL
and	NULL
are	NULL
produced	NULL
in	NULL
response	NULL
to	NULL
TNFa	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
C/EBPS	NULL
may	NULL
be	NULL
important	NULL
in	NULL
chronic	NULL
inflammation	NULL
associated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
disorders	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
C/	NULL
activity	NULL
,	NULL
perhaps	NULL
mediated	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
presents	NULL
a	NULL
potential	NULL
means	NULL
of	NULL
blocking	NULL
the	NULL
synthesis	NULL
of	NULL
cytokines	NULL
like	NULL
TNFa	NULL
which	NULL
contribute	NULL
to	NULL
chronic	NULL
inflammation	NULL
.	NULL

Further	NULL
work	NULL
with	NULL
dominant-negative	NULL
forms	NULL
of	NULL
will	NULL
be	NULL
required	NULL
to	NULL
determine	NULL
if	NULL
such	NULL
therapy	NULL
is	NULL
possible	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
commend	NULL
Yi	NULL
Shen	NULL
for	NULL
her	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
thank	NULL
S.	NULL
Akira	NULL
,	NULL
J.	NULL
Economou	NULL
,	NULL
and	NULL
P.	NULL
Johnson	NULL
for	NULL
their	NULL
generous	NULL
gifts	NULL
of	NULL
plasmids	NULL
,	NULL
antisera	NULL
,	NULL
and	NULL
bacterially	NULL
expressed	NULL
proteins	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

R.	NULL
M.	NULL
Pope	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Multipurpose	NULL
Arthritis	NULL
and	NULL
Musculoskeletal	NULL
Diseases	NULL
Center	NULL
grant	NULL
(	NULL
P6O-AR30692	NULL
)	NULL
,	NULL
by	NULL
the	NULL
Veterans	NULL
Administration	NULL
Research	NULL
Service	NULL
,	NULL
and	NULL
the	NULL
Illinois	NULL
Chapter	NULL
of	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
.	NULL

S.	NULL
A.	NULL
Ness	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Leukemia	NULL
Research	NULL
Foundation	NULL
and	NULL
the	NULL
Illinois	NULL
Division	NULL
of	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Firestein	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
J.	NULL
M.	NULL
Garcia-Alvaro	NULL
,	NULL
and	NULL
R.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

Quantitative	NULL
analysis	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3347-3353	NULL
.	NULL

2	NULL
.	NULL

Guermne	NULL
,	NULL
P.-A	NULL
.	NULL

,	NULL
B.	NULL
L.	NULL
Zuraw	NULL
,	NULL
J.	NULL
H.	NULL
Vaughan	NULL
,	NULL
D.	NULL
A.	NULL
Carson	NULL
,	NULL
and	NULL
M.	NULL
Lotz	NULL
.	NULL

1989	NULL
.	NULL

Synovium	NULL
as	NULL
a	NULL
source	NULL
of	NULL
interleukin	NULL
6	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

83:585-592	NULL
.	NULL

3	NULL
.	NULL

Koch	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
J.	NULL
C.	NULL
Burrows	NULL
,	NULL
H.	NULL
L.	NULL
Evanoff	NULL
,	NULL
G.	NULL
K.	NULL
Haines	NULL
,	NULL
R.	NULL
M.	NULL
Pope	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Strieter	NULL
.	NULL

1991	NULL
.	NULL

Synovial	NULL
tissue	NULL
macrophage	NULL
as	NULL
a	NULL
source	NULL
of	NULL
the	NULL
chemotactic	NULL
cytokine	NULL
IL-8	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2187-2195	NULL
.	NULL

4	NULL
.	NULL

Koch	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
S.	NULL
W.	NULL
Chensue	NULL
,	NULL
G.	NULL
K.	NULL
Haines	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Strieter	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
interleukin-1	NULL
and	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
by	NULL
human	NULL
rheumatoid	NULL
synovial	NULL
tissue	NULL
macrophages	NULL
.	NULL

Clin	NULL
.	NULL

immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

65:23-29	NULL
.	NULL

5	NULL
.	NULL

Koch	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
L.	NULL
A.	NULL
Harlow	NULL
,	NULL
B.	NULL
Johnson	NULL
,	NULL
H.	NULL
L.	NULL
Evanoff	NULL
,	NULL
G.	NULL
K.	NULL
Haines	NULL
,	NULL
M.	NULL
D.	NULL
Burdick	NULL
,	NULL
R.	NULL
M.	NULL
Pope	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Strieter	NULL
.	NULL

1992	NULL
.	NULL

Enhanced	NULL
production	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:772-779	NULL
.	NULL

6	NULL
.	NULL

Koch	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
L.	NULL
A.	NULL
Harlow	NULL
,	NULL
D.	NULL
D.	NULL
Mazarakis	NULL
,	NULL
G.	NULL
K.	NULL
Haines	NULL
,	NULL
M.	NULL
D.	NULL
Burdick	NULL
,	NULL
R.	NULL
M.	NULL
Pope	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Strieter	NULL
.	NULL

1994	NULL
.	NULL

Macrophage	NULL
inflammatory	NULL
protein-	NULL
la	NULL
.	NULL

A	NULL
novel	NULL
chemotactic	NULL
cytokine	NULL
for	NULL
macrophages	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

93:921~928	NULL
.	NULL

7	NULL
.	NULL

Koch	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
J.	NULL
Polverini	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
L.	NULL
A.	NULL
Harlow	NULL
,	NULL
L.	NULL
A.	NULL
DePietro	NULL
,	NULL
V.	NULL
N.	NULL
Elner	NULL
,	NULL
S.	NULL
G.	NULL
Elner	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Strieter	NULL
.	NULL

1992	NULL
.	NULL

Interleukin-8	NULL
as	NULL
a	NULL
macrophage-derived	NULL
mediator	NULL
of	NULL
angiogenesis	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

258:1798-1801	NULL
.	NULL

8	NULL
.	NULL

Gravallese	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Darling	NULL
,	NULL
A.	NULL
L.	NULL
Ladd	NULL
,	NULL
J.	NULL
N.	NULL
Katz	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1991	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
studies	NULL
of	NULL
stromelysin	NULL
and	NULL
collagenase	NULL
messenger	NULL
RNA	NULL
expression	NULL
in	NULL
rheumatoid	NULL
synovium	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

34:1076-1084	NULL
.	NULL

9	NULL
.	NULL

McCachren	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Niedel	NULL
.	NULL

1990	NULL
.	NULL

Localization	NULL
of	NULL
collagenase	NULL
mRNA	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
synovium	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
histochemistry	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

10:19-24	NULL
.	NULL

10	NULL
.	NULL

Dayer	NULL
,	NULL
J.-M.	NULL
,	NULL
B.	NULL
Beutler	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1985	NULL
.	NULL

Cachectin/tumor	NULL
necrosis	NULL
factor	NULL
stimulates	NULL
collagenase	NULL
and	NULL
prostaglandin	NULL
E	NULL
,	NULL
production	NULL
by	NULL
human	NULL
synovial	NULL
cells	NULL
and	NULL
dermal	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

162:2163-2168	NULL
.	NULL

11	NULL
.	NULL

DeForge	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
J.	NULL
S.	NULL
Kenney	NULL
,	NULL
M.	NULL
L.	NULL
Jones	NULL
,	NULL
J.	NULL
S.	NULL
Warren	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Remick	NULL
.	NULL

1992	NULL
.	NULL

Biphasic	NULL
production	NULL
of	NULL
IL-8	NULL
in	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-stimulated	NULL
human	NULL
whole	NULL
blood	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2133-2141	NULL
.	NULL

12	NULL
.	NULL

Vassalli	NULL
,	NULL
P.	NULL
1992	NULL
.	NULL

The	NULL
pathophysiology	NULL
of	NULL
tumor	NULL
necrosis	NULL
factors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:411-452	NULL
.	NULL

13	NULL
.	NULL

Webb	NULL
,	NULL
D.	NULL
S.	NULL
A.	NULL
,	NULL
Y.	NULL
Shimizu	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

Van	NULL
Seventer	NULL
,	NULL
S.	NULL
Shaw	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Gerrard	NULL
.	NULL

1990	NULL
.	NULL

LFA-3	NULL
,	NULL
CD44	NULL
,	NULL
and	NULL
CD45	NULL
:	NULL
physiologic	NULL
triggers	NULL
of	NULL
human	NULL
monocyte	NULL
TNF	NULL
and	NULL
IL-1	NULL
release	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

249:1295-1297	NULL
.	NULL

14	NULL
.	NULL

Yorochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
D.	NULL
Y.	NULL
Liu	NULL
,	NULL
D.	NULL
Eierman	NULL
,	NULL
and	NULL
S.	NULL
Haskill	NULL
.	NULL

1992	NULL
.	NULL

Integrins	NULL
as	NULL
a	NULL
primary	NULL
signal	NULL
transduction	NULL
molecule	NULL
regulating	NULL
monocyte	NULL
immediate-early	NULL
gene	NULL
induction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:9034-9038	NULL
.	NULL

15	NULL
.	NULL

Economou	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
K.	NULL
Rhoades	NULL
,	NULL
R.	NULL
Essner	NULL
,	NULL
W.	NULL
H.	NULL
McBride	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Morton	NULL
.	NULL

1989	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a/	NULL
cachectin	NULL
promoter	NULL
region	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:321-326	NULL
.	NULL

16	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
D.	NULL
Doyle	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:9769-9773	NULL
.	NULL

17	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
cyclosporin-sensitive	NULL
element	NULL
in	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1365-1379	NULL
.	NULL

18	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
C.	NULL
Doyle	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:73-81	NULL
.	NULL

19	NULL
.	NULL

Hensel	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Meichle	NULL
,	NULL
K.	NULL
Pfizenmaier	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1989	NULL
.	NULL

PMA-responsive	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
gene	NULL
.	NULL

Lymphokine	NULL
Res	NULL
.	NULL

8:347-351	NULL
.	NULL

20	NULL
.	NULL

Leitman	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
E.	NULL
R.	NULL
Mackow	NULL
,	NULL
T.	NULL
Williams	NULL
,	NULL
J.	NULL
D.	NULL
Baxter	NULL
,	NULL
and	NULL
B.	NULL
L.	NULL
West	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
core	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
confers	NULL
phorbol	NULL
ester	NULL
responsiveness	NULL
to	NULL
upstream	NULL
transcriptional	NULL
activators	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1352-1356	NULL
.	NULL

21	NULL
.	NULL

Leitman	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
R.	NULL
C.	NULL
J.	NULL
Ribeiro	NULL
,	NULL
E.	NULL
R.	NULL
Mackow	NULL
,	NULL
J.	NULL
D.	NULL
Baxter	NULL
,	NULL
and	NULL
B.	NULL
L.	NULL
West	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
tumor	NULL
necrosis	NULL
factor-responsive	NULL
element	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9343-9346	NULL
.	NULL

22	NULL
.	NULL

Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
S.	NULL
H.	NULL
Golub	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Economou	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
promoter	NULL
region	NULL
in	NULL
macrophage	NULL
,	NULL
T	NULL
cell	NULL
,	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:22102-22107	NULL
.	NULL

23	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
M.	NULL
Umek	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

5:1538-1552	NULL
.	NULL

24	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
O.	NULL
Tanabe	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
,	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:1897-1906	NULL
.	NULL

25	NULL
.	NULL

Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Strobel	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
P.	NULL
Wendelga	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
E.	NULL
Stemeck	NULL
,	NULL
G.	NULL
Riethmuller	NULL
,	NULL
and	NULL
H.	NULL
W.	NULL
Loms	NULL
Ziegler-Heitbrock	NULL
.	NULL

1992	NULL
.	NULL

Constitutive	NULL
monocyte-restricted	NULL
activity	NULL
of	NULL
NF-M	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
C/EBP	NULL
motif	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:237-243	NULL
.	NULL

26	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:8145-8149	NULL
.	NULL

27	NULL
.	NULL

Ness	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
E.	NULL
Kowenz-Leutz	NULL
,	NULL
T.	NULL
Casini	NULL
,	NULL
T.	NULL
Graf	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1993	NULL
.	NULL

Myb	NULL
and	NULL
MF-M	NULL
:	NULL
combinatorial	NULL
activators	NULL
of	NULL
myeloid	NULL
genes	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7:749-759	NULL
.	NULL

28	NULL
.	NULL

Nishio	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
interleukin-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
synergisti-cally	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
rat	NULL
al-acid	NULL
glycoprotein	NULL
gene	NULL
via	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1854-1862	NULL
.	NULL

29	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
associations	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
:	NULL
a	NULL
rel	NULL
domain-bZIP	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3964-3974	NULL
.	NULL

30	NULL
.	NULL

Grove	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
Plumb	NULL
.	NULL

1993	NULL
.	NULL

C/EBP	NULL
,	NULL
NF-xB	NULL
,	NULL
and	NULL
c-Ets	NULL
family	NULL
members	NULL
and	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
cell-specific	NULL
and	NULL
inducible	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
la	NULL
immediate-early	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5276-5289	NULL
.	NULL

31	NULL
.	NULL

Katz	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Kowenz-Leutz	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
K.	NULL
Meese	NULL
,	NULL
S.	NULL
A.	NULL
Ness	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-M	NULL
transcription	NULL
factor	NULL
is	NULL
related	NULL
to	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
and	NULL
leukemogenesis	NULL
of	NULL
avian	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:1321-1332	NULL
.	NULL

32	NULL
.	NULL

Nomiyama	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Keishima	NULL
,	NULL
K.	NULL
Hirokawa	NULL
,	NULL
T.	NULL
Hattori	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
R.	NULL
Miura	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
cytokine	NULL
LD78	NULL
gene	NULL
promoters	NULL
:	NULL
positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
factors	NULL
bind	NULL
to	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
common	NULL
to	NULL
LD78	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2787-2801	NULL
.	NULL

33	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
K.	NULL
Saito	NULL
,	NULL
C.	NULL
A.	NULL
Bonagura	NULL
,	NULL
D.	NULL
L.	NULL
Galson	NULL
,	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
A.C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
human	NULL
prointerleukin	NULL
13	NULL
gene	NULL
requires	NULL
DNA	NULL
sequences	NULL
both	NULL
proximal	NULL
and	NULL
distal	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
for	NULL
tissue-specific	NULL
induction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1332-1344	NULL
.	NULL

34	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Distinct	NULL
mechanisms	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-8	NULL
gene	NULL
involve	NULL
synergism	NULL
and	NULL
cooperativity	NULL
between	NULL
C/EBP	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7191-7198	NULL
.	NULL

35	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
W.	NULL
N.	NULL
Rom	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
(	NULL
IL-18	NULL
)	NULL
gene	NULL
by	NULL
mycobacteria	NULL
components	NULL
and	NULL
lipopolysaccharide	NULL
is	NULL
mediated	NULL
by	NULL
two	NULL
nuclear	NULL
factor-IL6	NULL
motifs	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3831-3837	NULL
.	NULL

36	NULL
.	NULL

Schrieber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
*'mini-extracts	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

37	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Lipopolysaccharide	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage-specific	NULL
stimulator	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
.	NULL

J	NULL
.	NULL

£xp	NULL
.	NULL

Med	NULL
.	NULL

172:253-261	NULL
.	NULL

38	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
W.	NULL
Keller	NULL
,	NULL
T.	NULL
Dale	NULL
,	NULL
H.	NULL
R.	NULL
Scholer	NULL
,	NULL
G.	NULL
Tabb	NULL
,	NULL
and	NULL
I.	NULL
Mattaj	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
transcription	NULL
factor	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
enhancers	NULL
of	NULL
SV40	NULL
,	NULL
immunoglobu-lin	NULL
heavy	NULL
chain	NULL
and	NULL
U2	NULL
snRNA	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

325:268-272	NULL
.	NULL

39	NULL
.	NULL

Trautwein	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Caelles	NULL
,	NULL
P.	NULL
van	NULL
der	NULL
Geer	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
M.	NULL
Choijkier	NULL
.	NULL

1993	NULL
.	NULL

Transactivation	NULL
by	NULL
NF-IL6/LAP	NULL
is	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
activation	NULL
domain	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

364:544-547	NULL
.	NULL

40	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
.	NULL

79:460-466	NULL
.	NULL

41	NULL
.	NULL

Scott	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
C.	NULL
I.	NULL
Civin	NULL
,	NULL
P.	NULL
Rorth	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Friedman	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
three	NULL
C/EBP	NULL
family	NULL
members	NULL
in	NULL
differentiating	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

80:1725-1735	NULL
.	NULL

42	NULL
.	NULL

Williams	NULL
,	NULL
$	NULL
.	NULL

C.	NULL
,	NULL
C.	NULL
A.	NULL
Cantwell	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Johnson	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
family	NULL
of	NULL
C/	NULL
EBP-related	NULL
proteins	NULL
capable	NULL
of	NULL
forming	NULL
covalently	NULL
linked	NULL
leucine	NULL
zipper	NULL
dimers	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

5:1553-1567	NULL
.	NULL

43	NULL
.	NULL

Stemmeck	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Blattner	NULL
,	NULL
T.	NULL
Graf	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1992	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
chicken	NULL
myelomonocytic	NULL
growth	NULL
factor	NULL
gene	NULL
and	NULL
specific	NULL
activation	NULL
of	NULL
its	NULL
promoter	NULL
in	NULL
avian	NULL
myelomonocytic	NULL
cells	NULL
by	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1728-1735	NULL
.	NULL

44	NULL
.	NULL

Chu	NULL
,	NULL
C.	NULL
Q.	NULL
,	NULL
M.	NULL
Field	NULL
,	NULL
M.	NULL
Feldmann	NULL
,	NULL
and	NULL
R.	NULL
N.	NULL
Maini	NULL
.	NULL

1991	NULL
.	NULL

Localization	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
in	NULL
synovial	NULL
tissues	NULL
and	NULL
at	NULL
the	NULL
cartilage-pannus	NULL
junction	NULL
in	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

34:1125-1132	NULL
.	NULL

45	NULL
.	NULL

MacNaul	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
N.	NULL
I.	NULL
Hutchinson	NULL
,	NULL
J.	NULL
N.	NULL
Parson	NULL
,	NULL
E.	NULL
K.	NULL
Bayne	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Tocci	NULL
.	NULL

1990	NULL
.	NULL

Analysis	NULL
of	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
rheumatoid	NULL
synoviocytes	NULL
and	NULL
normal	NULL
monocytes	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:4154-4166	NULL
.	NULL

46	NULL
.	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
synergis-tically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:10193-10197	NULL
.	NULL

47	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Imagawa	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
R.	NULL
J.	NULL
Imbra	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
C.	NULL
Jonat	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Phorbol	NULL
ester-inducible	NULL
genes	NULL
contain	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA-modulated	NULL
frans-activating	NULL
factor	NULL
.	NULL

Cell	NULL
.	NULL

49:729-739	NULL
.	NULL

48	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

49	NULL
.	NULL

Hsu	NULL
,	NULL
W.	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
P.-L.	NULL
Chen	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1994	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
repress	NULL
transcription	NULL
activation	NULL
by	NULL
NF-IL6	NULL
through	NULL
association	NULL
at	NULL
the	NULL
basic	NULL
zipper	NULL
region	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:268-276	NULL
.	NULL

C/EBP	NULL
B	NULL
Regulates	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Expression	NULL
1455	NULL

